For further experiments we decided to work with the two UC cell lines RT112 (overexpressing FGFR3) and T24 (oncogenic H-Ras, homozygous PTEN mutation), both exhibiting frequently found genomic alterations in bladder cancer [39], [40], [41]. Here, HRAS is linked to urinary bladder carcinoma.